Antimalarial development

被引：0
|
作者：
Bradbury, Jane
机构：
来源：
LANCET INFECTIOUS DISEASES | 2013年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：924 / 924
页数：1
相关论文
共 50 条
  • [21] Bilayer Perturbation is a Predictive Parameter for Antimalarial Development
    Ramsey, Nicole
    Andersen, Olaf
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 83A - 84A
  • [22] Development and application of a PBPK modeling strategy to support antimalarial drug development
    Abla, Nada
    Howgate, Eleanor
    Rowland-Yeo, Karen
    Dickins, Maurice
    Bergagnini-Kolev, Mackenzie C. C.
    Chen, Kuan-Fu
    McFeely, Savannah
    Bonner, Jennifer J. J.
    Santos, Laura G. A.
    Gobeau, Nathalie
    Burt, Howard
    Barter, Zoe
    Jones, Hannah M. M.
    Wesche, David
    Charman, Susan A. A.
    Moehrle, Jorg J.
    Burrows, Jeremy N. N.
    Almond, Lisa M. M.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (09): : 1335 - 1346
  • [23] Army Antimalarial Drug Development: An Advanced Development Case Study for Tafenoquine
    Zottig, Victor E.
    Carr, Katherine A.
    Clarke, John G.
    Shmuklarsky, Moshe J.
    Kreishman-Deitrick, Mara
    MILITARY MEDICINE, 2020, 185 : 617 - 623
  • [24] Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
    Chaniad, Prapaporn
    Techarang, Tachpon
    Phuwajaroanpong, Arisara
    Plirat, Walaiporn
    Viriyavejakul, Parnpen
    Septama, Abdi Wira
    Punsawad, Chuchard
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [25] Antimalarial efficacy and toxicological assessment of medicinal plant ingredients of Prabchompoothaweep remedy as a candidate for antimalarial drug development
    Prapaporn Chaniad
    Tachpon Techarang
    Arisara Phuwajaroanpong
    Walaiporn Plirat
    Parnpen Viriyavejakul
    Abdi Wira Septama
    Chuchard Punsawad
    BMC Complementary Medicine and Therapies, 23
  • [26] Challenges in the development of antimalarial drugs with causal prophylactic activity
    Chulay, JD
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (06) : 577 - 579
  • [27] The development of new antimalarial drugs: Qinghaosu and dihydroqinghaosu
    屠呦呦
    中华医学杂志(英文版), 1999, (11) : 17 - 18
  • [28] Development of a Plasmodium PCR for monitoring efficacy of antimalarial treatment
    Ciceron, L
    Jaureguiberry, G
    Gay, F
    Danis, M
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (01) : 35 - 38
  • [29] IN SILICO PRIORITIZATION OF LIBRARY COMPOUNDS FOR ANTIMALARIAL DRUG DEVELOPMENT
    Miruka, Silviane A.
    Mogire, Reagan M.
    Juma, Dennis W.
    Andagalu, Ben
    Ogutu, Bernhards R.
    Duffy, James
    Chenu, Elodie
    Akala, Hosea M.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 67 - 68
  • [30] The Global Portfolio of New Antimalarial Medicines Under Development
    Olliaro, P.
    Wells, T. N. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) : 584 - 595
12345